QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors

NCT05108779 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Tumor

Interventions

DRUG: QLF32004

Sponsor

Qilu Pharmaceutical Co., Ltd.